Nursing: Non Cancer Pain Management for New Mexico Advanced Practice Nurses
34.95
About the Course:
Advanced Practice Nurses (APNs) have a responsibility to understand the appropriate use of opioid medications and the risks inherent to this category of therapeutic products. Furthermore, the New Mexico Board of Nursing requires five hours of non-cancer pain management continuing education for license renewal. Additionally, effective June 14, 2019, the New Mexico legislature passed new requirements governing the prescribing of prescription opioid medications. This educational program is specifically designed to meet the continuing education requirements for New Mexico APNs and outline their responsibilities under state law. A solid understanding of non-cancer pain management, opioids, their use, misuse and potential solutions to this public health issue will greatly contribute to improved patient health and quality of life.
Many New Mexico APNs are likely to encounter patients in severe pain requiring treatment with opioid pain medications across multiple practice settings exclusive of cancer. It is critical that they are well-versed in the federal and state laws governing the prescribing of these products. In addition to these statutory guidelines, APNs must understand and appreciate how differing clinical use guidelines can be safely and effectively applied to various practice settings and populations. The purpose of this course is to provide an accredited continuing education program designed to satisfy specific opioid clinical use continuing education requirements as described in Rule 9, Section 8 by the New Mexico Board of Nursing. Additionally, this educational program will provide APNs an overview of the legal requirements governing the prescribing of opioids in New Mexico.
Learning Outcomes:
Upon completion of this course, the learner will be able to:
About the Author:
Bradley Gillespie, PharmD, trained as a clinical pharmacist and has practiced in an industrial setting for the past 25+ years. His initial role was as a Clinical Pharmacology and Biopharmaceutics reviewer at the FDA, followed by 20 years of leading Early Development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist, enjoys mentoring drug development scientists and health professionals, leading workshops, and developing continuing education programs for pharmacy, nursing, and other medical professionals.
How to receive credit:
Disclosures:
Resolution of Conflict of Interest
In accordance with the ANCC Standards for Commercial Support for continuing education, Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.
Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition
©2020: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
Course Verification
All individuals involved have disclosed that they have no significant financial or other conflicts of interest pertaining to this course. Likewise, and in compliance with California Assembly Bill No. 241, every reasonable effort has been made to ensure that the content in this course is balanced and unbiased.
Advanced Practice Nurses (APNs) have a responsibility to understand the appropriate use of opioid medications and the risks inherent to this category of therapeutic products. Furthermore, the New Mexico Board of Nursing requires five hours of non-cancer pain management continuing education for license renewal. Additionally, effective June 14, 2019, the New Mexico legislature passed new requirements governing the prescribing of prescription opioid medications. This educational program is specifically designed to meet the continuing education requirements for New Mexico APNs and outline their responsibilities under state law. A solid understanding of non-cancer pain management, opioids, their use, misuse and potential solutions to this public health issue will greatly contribute to improved patient health and quality of life.
Many New Mexico APNs are likely to encounter patients in severe pain requiring treatment with opioid pain medications across multiple practice settings exclusive of cancer. It is critical that they are well-versed in the federal and state laws governing the prescribing of these products. In addition to these statutory guidelines, APNs must understand and appreciate how differing clinical use guidelines can be safely and effectively applied to various practice settings and populations. The purpose of this course is to provide an accredited continuing education program designed to satisfy specific opioid clinical use continuing education requirements as described in Rule 9, Section 8 by the New Mexico Board of Nursing. Additionally, this educational program will provide APNs an overview of the legal requirements governing the prescribing of opioids in New Mexico.
Learning Outcomes:
Upon completion of this course, the learner will be able to:
- Understand the pharmacology and risk associated with opioid use.
- Suggest one factor that may have contributed to the current increase in opioid usage.
- Explain one regulatory objective of the Controlled Substances Act of 1970 (CSA).
- Name one medication classified as Schedule IV by the CSA.
- Provide a reason for why opioid analgesics may not be an ideal first line treatment option for pain.
- Describe the potential value of toxicology screens as a part of opioid therapy.
- State one category of medications that should be used with caution in conjunction with opioids.
- Provide one guideline for consideration when initiating opioid therapy for pain management.
- Name a tool with some utility for characterizing the risk of opioid addiction.
- Explain the risks of renarcotization.
About the Author:
Bradley Gillespie, PharmD, trained as a clinical pharmacist and has practiced in an industrial setting for the past 25+ years. His initial role was as a Clinical Pharmacology and Biopharmaceutics reviewer at the FDA, followed by 20 years of leading Early Development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist, enjoys mentoring drug development scientists and health professionals, leading workshops, and developing continuing education programs for pharmacy, nursing, and other medical professionals.
How to receive credit:
- Read the entire course online or in print which requires a 5-hour commitment of time.
- Complete the self-assessment quiz questions which are at the end of the course or integrated throughout the course. These questions are NOT GRADED. The correct answer is shown after you answer the question. If the incorrect answer is selected, the rationale for the correct answer is provided. These questions help to affirm what you have learned from the course.
- Depending on your state requirements you will then be asked to complete either:
- An affirmation that you have completed the educational activity
- A mandatory test (a passing score of 70 percent is required). Test questions link content to learning objectives as a method to enhance individualized learning and material retention.
- If requested, provide required personal information and payment information.
- Complete the mandatory Course Evaluation.
Disclosures:
Resolution of Conflict of Interest
In accordance with the ANCC Standards for Commercial Support for continuing education, Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.
Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition
©2020: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
Course Verification
All individuals involved have disclosed that they have no significant financial or other conflicts of interest pertaining to this course. Likewise, and in compliance with California Assembly Bill No. 241, every reasonable effort has been made to ensure that the content in this course is balanced and unbiased.
View Requirements
Want Unlimited CE? Become a Member
Non Cancer Pain Management for New Mexico Advanced Practice Nurses - N36892
34.95
About the Course:
Advanced Practice Nurses (APNs) have a responsibility to understand the appropriate use of opioid medications and the risks inherent to this category of therapeutic products. Furthermore, the New Mexico Board of Nursing requires five hours of non-cancer pain management continuing education for license renewal. Additionally, effective June 14, 2019, the New Mexico legislature passed new requirements governing the prescribing of prescription opioid medications. This educational program is specifically designed to meet the continuing education requirements for New Mexico APNs and outline their responsibilities under state law. A solid understanding of non-cancer pain management, opioids, their use, misuse and potential solutions to this public health issue will greatly contribute to improved patient health and quality of life.
Many New Mexico APNs are likely to encounter patients in severe pain requiring treatment with opioid pain medications across multiple practice settings exclusive of cancer. It is critical that they are well-versed in the federal and state laws governing the prescribing of these products. In addition to these statutory guidelines, APNs must understand and appreciate how differing clinical use guidelines can be safely and effectively applied to various practice settings and populations. The purpose of this course is to provide an accredited continuing education program designed to satisfy specific opioid clinical use continuing education requirements as described in Rule 9, Section 8 by the New Mexico Board of Nursing. Additionally, this educational program will provide APNs an overview of the legal requirements governing the prescribing of opioids in New Mexico.
Learning Outcomes:
Upon completion of this course, the learner will be able to:
About the Author:
Bradley Gillespie, PharmD, trained as a clinical pharmacist and has practiced in an industrial setting for the past 25+ years. His initial role was as a Clinical Pharmacology and Biopharmaceutics reviewer at the FDA, followed by 20 years of leading Early Development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist, enjoys mentoring drug development scientists and health professionals, leading workshops, and developing continuing education programs for pharmacy, nursing, and other medical professionals.
How to receive credit:
Disclosures:
Resolution of Conflict of Interest
In accordance with the ANCC Standards for Commercial Support for continuing education, Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.
Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition
©2020: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
Course Verification
All individuals involved have disclosed that they have no significant financial or other conflicts of interest pertaining to this course. Likewise, and in compliance with California Assembly Bill No. 241, every reasonable effort has been made to ensure that the content in this course is balanced and unbiased.
Advanced Practice Nurses (APNs) have a responsibility to understand the appropriate use of opioid medications and the risks inherent to this category of therapeutic products. Furthermore, the New Mexico Board of Nursing requires five hours of non-cancer pain management continuing education for license renewal. Additionally, effective June 14, 2019, the New Mexico legislature passed new requirements governing the prescribing of prescription opioid medications. This educational program is specifically designed to meet the continuing education requirements for New Mexico APNs and outline their responsibilities under state law. A solid understanding of non-cancer pain management, opioids, their use, misuse and potential solutions to this public health issue will greatly contribute to improved patient health and quality of life.
Many New Mexico APNs are likely to encounter patients in severe pain requiring treatment with opioid pain medications across multiple practice settings exclusive of cancer. It is critical that they are well-versed in the federal and state laws governing the prescribing of these products. In addition to these statutory guidelines, APNs must understand and appreciate how differing clinical use guidelines can be safely and effectively applied to various practice settings and populations. The purpose of this course is to provide an accredited continuing education program designed to satisfy specific opioid clinical use continuing education requirements as described in Rule 9, Section 8 by the New Mexico Board of Nursing. Additionally, this educational program will provide APNs an overview of the legal requirements governing the prescribing of opioids in New Mexico.
Learning Outcomes:
Upon completion of this course, the learner will be able to:
- Understand the pharmacology and risk associated with opioid use.
- Suggest one factor that may have contributed to the current increase in opioid usage.
- Explain one regulatory objective of the Controlled Substances Act of 1970 (CSA).
- Name one medication classified as Schedule IV by the CSA.
- Provide a reason for why opioid analgesics may not be an ideal first line treatment option for pain.
- Describe the potential value of toxicology screens as a part of opioid therapy.
- State one category of medications that should be used with caution in conjunction with opioids.
- Provide one guideline for consideration when initiating opioid therapy for pain management.
- Name a tool with some utility for characterizing the risk of opioid addiction.
- Explain the risks of renarcotization.
About the Author:
Bradley Gillespie, PharmD, trained as a clinical pharmacist and has practiced in an industrial setting for the past 25+ years. His initial role was as a Clinical Pharmacology and Biopharmaceutics reviewer at the FDA, followed by 20 years of leading Early Development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist, enjoys mentoring drug development scientists and health professionals, leading workshops, and developing continuing education programs for pharmacy, nursing, and other medical professionals.
How to receive credit:
- Read the entire course online or in print which requires a 5-hour commitment of time.
- Complete the self-assessment quiz questions which are at the end of the course or integrated throughout the course. These questions are NOT GRADED. The correct answer is shown after you answer the question. If the incorrect answer is selected, the rationale for the correct answer is provided. These questions help to affirm what you have learned from the course.
- Depending on your state requirements you will then be asked to complete either:
- An affirmation that you have completed the educational activity
- A mandatory test (a passing score of 70 percent is required). Test questions link content to learning objectives as a method to enhance individualized learning and material retention.
- If requested, provide required personal information and payment information.
- Complete the mandatory Course Evaluation.
Disclosures:
Resolution of Conflict of Interest
In accordance with the ANCC Standards for Commercial Support for continuing education, Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.
Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition
©2020: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
Course Verification
All individuals involved have disclosed that they have no significant financial or other conflicts of interest pertaining to this course. Likewise, and in compliance with California Assembly Bill No. 241, every reasonable effort has been made to ensure that the content in this course is balanced and unbiased.